Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase 1 3Phase 4 2Phase 1/2 2Phase NA 1

Status

Completed 4Unknown 3Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 1

Conditions

Leukemia, Promyelocytic, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Arsenic Trioxide × Clear all
NCT02899169 2021-09-08

APL16

First Affiliated Hospital Xi'an Jiaotong University

Phase 3 Unknown
110 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT02757040 2016-04-29

Combination of Ibrutinib and As2O3 in the Treatment of CLL

Peking University People's Hospital

Phase 3 Unknown
70 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00378365 2014-04-16

Acute Promyelocytic Leukemia 2006 (APL)

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown
800 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡